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The epithelial to mesenchymal transition (EMT) plays crucial roles in the formation of the body 
plan and in the differentiation of multiple tissues and organs. EMT also contributes to tissue repair, 
but it can adversely cause organ fibrosis and promote carcinoma progression through a variety 
of mechanisms. EMT endows cells with migratory and invasive properties, induces stem cell 
properties, prevents apoptosis and senescence, and contributes to immunosuppression. Thus, 
the mesenchymal state is associated with the capacity of cells to migrate to distant organs and 
maintain stemness, allowing their subsequent differentiation into multiple cell types during devel-
opment and the initiation of metastasis.Most adult tissues and organs arise from a series of conversions 
of epithelial cells to mesenchymal cells, through the epithelial to 
mesenchymal transition (EMT) and the reverse process (mesen-
chymal to epithelial transition [MET]). Epithelial cells establish close 
contacts with their neighbors and an apicobasal axis of polarity 
through the sequential arrangement of adherens junctions, des-
mosomes, and tight junctions. The epithelial cell layer maintains 
global communication through gap junctional complexes, and it 
remains separated from adjacent tissues by a basal lamina. Epi-
thelia have the capacity to function as barriers or in absorption. 
Conversely, mesenchymal or stromal cells are loosely organized 
in a three-dimensional extracellular matrix and comprise connec-
tive tissues adjacent to epithelia. The conversion of epithelial cells 
to mesenchymal cells is fundamental for embryonic development 
and involves profound phenotypic changes that include the loss 
of cell-cell adhesion, the loss of cell polarity, and the acquisition 
of migratory and invasive properties.
This review presents the events in development that involve 
EMT and discusses its relevance in tissue homeostasis, tissue 
repair, fibrosis, and carcinoma progression. We also examine 
the impact of EMT on drug resistance and explore recent find-
ings that reinforce the concept of EMT as a major driver of mor-
phogenesis and tumor progression.
Development: Primary, Secondary, and Tertiary EMT
The transition of epithelial to mesenchymal cells is not irreversible, 
as several rounds of EMT and MET are necessary for the final 
differentiation of specialized cell types and the acquisition of the 
complex three-dimensional structure of internal organs. Accord-
ingly, these sequential rounds are referred to as primary, second-
ary, and tertiary EMT (Figure 1). Examples of primary EMT include 
those evident during mammalian implantation, during gastrulation 
in various metazoans, and in the neural crest of all vertebrates.Gastrulation
Although the morphogenetic movements associated with gastru-
lation vary among metazoans, it is the universal process by which 
the body plan is established. The necessary changes in cell shape 
are followed by internalization of the mesendoderm, convergence 
to the midline, and extension along the anteroposterior axis. A 
crucial structure in all organisms is the region where cells invo-
lute or ingress (the ventral furrow in Drosophila, the blastopore in 
Xenopus, and the primitive streak in the chick and mouse). In ver-
tebrates, this region contains an organizing center known as the 
Spemann organizer in Xenopus, the shield in fish, and the node in 
birds and mammals. To understand how gastrulation proceeds, it 
is necessary to consider the successive inductive processes that 
occur before or at the time when the organizer forms and to iden-
tify the molecular elements involved. Interestingly, some of the 
most important elements are conserved throughout evolution.
Gastrulation in Invertebrates
The sea urchin is amenable to detailed fate mapping and 
molecular embryology approaches, leading to the generation 
of an extensive gene regulatory network at gastrulation (Oliveri 
et al., 2008) (Figure 2A). Key in this network are the transcrip-
tion factors Snail and Twist, which are evolutionary conserved 
repressors of E-cadherin and inducers of EMT (Peinado et al., 
2007). In the sea urchin, Snail inhibits E-cadherin transcription 
and promotes cadherin endocytosis as well as the delamina-
tion of primary mesenchyme cells (PMCs) by EMT (Wu et al., 
2007), whereas its inhibition blocks PMC ingression. In turn, 
inhibition of Twist function delays the ingression of PMCs (Wu 
et al., 2008).
As in sea urchin, Twist and Snail are crucial factors in fly 
gastrulation (Figure 2B). Apical constriction is necessary for 
ventral furrow formation and cell invagination, and this process 
requires Twist and its target, T48. These proteins are recruited Cell 139, November 25, 2009 ©2009 Elsevier Inc. 871
to the adherens junctions, producing rapid changes in cell 
shape in conjunction with RhoGEF2, a Rho GTP-exchange fac-
tor and cytoskeletal regulator that concentrates at the site of 
apical constriction (Kolsch et al., 2007). Snail is also required 
for ventral furrow formation, the cells of which express string, 
a cdc25 homolog essential for entry into mitosis. Snail-depen-
dent string inhibition generates the mitotic block necessary for 
gastrulation to occur (Grosshans and Wieschaus, 2000). Simul-
taneously, Snail represses E-cadherin transcription (Oda et al., 
1998) and generates the pulses of myosin contraction required 
for apical constriction while Twist maintains the constricted 
state between pulses (Martin et al., 2009). In vertebrates, T48 
is not conserved, and Twist is not crucial for gastrulation, sug-
gesting that Snail may fulfill all of these functions.
Gastrulation in Vertebrates
In Xenopus, the Spemann organizer is induced by the Nieu-
wkoop center, a group of dorsal blastula cells characterized 
by the nuclear accumulation of β-catenin. Wnt signaling initi-
ates the process, and Goosecoid is induced in the Spemann 
organizer by its target, Siamois, and by 
several transforming growth factor β 
(TGFβ) superfamily members, including 
Nodal (Gilbert, 2006). In amniotes, acti-
vation of Wnt signaling confers compe-
tence to the posterior part of the embryo 
in the formation of the primitive streak 
(Figure 2C). Subsequently, members of 
the TGFβ superfamily, including Nodal 
and Vg1, induce gastrulation. Nodal sig-
naling, together with fibroblast growth 
factor (FGF), controls the specification 
of the mesendoderm in all vertebrates 
(Figure 2C). Thus, in preparation for 
EMT, numerous signaling pathways help establish an organiz-
ing center that in turn controls morphogenetic movements and 
specification (Heisenberg and Solnica-Krezel, 2008).
There are two main Snail genes in vertebrates, Snail1 and 
Snail2 (called SNAI1 and SNAI2 in humans). They are induced 
by TGFβ superfamily members, and FGF signaling is neces-
sary to maintain their expression and for gastrulation to pro-
ceed (Barrallo-Gimeno and Nieto, 2005; Ciruna and Rossant, 
2001). Snail-deficient embryos fail to gastrulate, and “meso-
dermal” cells are unable to downregulate E-cadherin accu-
mulate at the streak (Carver et al., 2001; Nieto et al., 1994). 
Snail proteins are not essential for mesodermal fate specifi-
cation as a “mesodermal” population expressing the appro-
priate markers still forms in Snail mutant mice, although cells 
fail to migrate because it cannot undergo EMT (Carver et al., 
2001). Furthermore, diploblasts (animals derived from only 
two germ layers) that do not form mesoderm also express 
snail in the regions of involution or ingression during endo-
derm formation. Hence, Snail activity is not associated with 
Figure 1. Successive EMT during 
 Embryonic Development
(A) Primary EMT occurs early during embryonic 
development, even before implantation such as 
during the formation of the parietal endoderm 
in mice. The first EMT after implantation is that 
undergone by the mesendodermal progenitors 
during gastrulation, whereas the delamination of 
neural crest cells from the dorsal neural tube is a 
later event.
(B) Early mesodermal cells are subdivided into 
axial, paraxial, intermediate, and lateral plate me-
sodermal cells that will condense into transient 
epithelial structures: the notochord, the somites, 
and the somatopleure and splanchnopleure, re-
spectively. These transient structures will undergo 
secondary EMT, leading to the generation of mes-
enchymal cells that differentiate into specific cell 
types. Endodermal tissues, including the pancreas 
bud and the liver diverticulum, exhibit morphologi-
cal changes reminiscent of a secondary EMT to in-
duce the dissociation of endocrine cells and hepa-
toblasts from their respective epithelial primordia.
(C) An example of tertiary EMT arises during the 
formation of the cushion mesenchyme in the heart 
from the atrioventricular canal (AV) or the outflow 
tract (OT). The cushion mesenchyme is the precur-
sor of the cardiac valves.872 Cell 139, November 25, 2009 ©2009 Elsevier Inc.
the mesodermal lineage but rather with changes in cell shape, 
cell adhesion, and cell movements, consistent with the notion 
that cell fate specification and morphogenetic movements 
are independent processes even though they occur simulta-
neously.
Given that gastrulation is a very rapid process, the regulation 
of E-cadherin transcription alone is insufficient. E-cadherin is 
also controlled at the protein level by the P38 interacting pro-
tein (IP), p38-MAP kinase, and the FERM protein (EPB4.1L5) 
(Figure 2C) (Zohn et al., 2006; Hirano et al., 2008; Lee et al., 
2007).
Other transcription factors such as Eomesodermin (Eomes) 
and Mesp1 and 2 are important for EMT during mouse gas-
trulation (Figure 2C). Eomes is a T-box transcription factor 
expressed in the posterior epiblast prior to streak formation, 
in the streak and in nascent mesendoderm at gastrulation. In 
turn, the basic helix-loop-helix transcription factors Mesp1 and 
2 are also expressed in the posterior epiblast of the mouse 
embryo. Mesodermal delamination from the streak is blocked 
in mice lacking Eomes in the epiblast and in double Mesp1/
Mesp2 mutants (Kitajima et al., 2000; Arnold et al., 2008). This 
is consistent with the ability of Mesp proteins to induce Snail 
and EMT in differentiated embryonic stem cells (Lindsley et al., 
2008).
Cells need to break the basal membrane to successfully 
delaminate from the primitive streak. A pathway mediated 
by the RhoGEF protein Net1 induces RhoA downregulation 
in the primitive streak and disrupts the interaction between 
epiblast cells and the underlying the basal membrane (Fig-
ure 2C) (Nakaya et al., 2008). Snail factors contribute to 
basal membrane degradation by activating metallopro-
teases (Jorda et al., 2005) and by repressing some compo-
nents such as Laminin5 and its receptors (Haraguchi et al., 
2008). Importantly, the integrity of the basal membrane must 
be maintained in areas outside of the primitive streak and 
the transmembrane protein FLRT3 seems to offer protection 
against its disruption in addition to regulating cell fate (Fig-
ure 2C) (Egea et al., 2008).
Unlike in the sea urchin or in Drosophila, the gene regulatory 
networks operating at gastrulation in vertebrates are far from 
complete. Future studies of EMT would benefit from the appli-
cation of genome-wide approaches and in vivo cell imaging. 
Figure 2. Genetic Pathways Governing 
Gastrulation
(A) The gene regulatory network governing EMT 
during gastrulation in the sea urchin embryo. A 
specification step involving Wnt8 signaling leads 
to HesC repression, switching on the EMT regula-
tory program, and inducing the ingression of the 
primary mesenchymal cells (PMCs). Alx1, arista-
less-like 1.
(B) Mesoderm invagination in Drosophila. Twist 
and Snail pathways cooperate to modulate cell 
adhesion and cytoskeletal changes to undergo 
gastrulation movements and mesoderm spread-
ing. The arrows indicate the flow of the pathway, 
not direct transcriptional regulation. Abl, Abelson 
kinase; Htl, Heartless (Drosophila FGF receptor); 
Dof, downstream of FGFR; Fog/Cta, folded in gas-
trulation/concertina.
(C) Genetic pathways controlling gastrulation in 
amniotes. Convergence of signaling pathways at 
the posterior part of the embryo leads to primi-
tive streak formation and initiation of the EMT 
as well as the mesodermal fate program. Snail 
genes are key regulators of the EMT program dur-
ing gastrulation in amniotes as they control cell-
cell adhesion, cell shape, and motility. Additional 
mechanisms such as endocytosis, lysosomal tar-
geting, and degradation of the E-cadherin protein 
together with the control of basement membrane 
integrity explain the rapid and drastic changes oc-
curring in ingressing cells during gastrulation. The 
induction of endodermal and mesodermal fates is 
mainly governed by the FGF and Nodal pathways 
through specific regulators and the contribution of 
some of the genes involved in the EMT program. 
EPB4L5, FERM and actin-binding domains-con-
taining band 4.1 superfamily member; FLRT3, Fi-
bronectin-leucine-rich-transmembrane protein-3; 
Net-1, neuroepithelial transforming factor 1; MMP, 
metalloproteinases; p38IK, p38 interacting kinase.Cell 139, November 25, 2009 ©2009 Elsevier Inc. 873
Indeed, attempts to define the transcriptome in the gastrulating 
mouse embryo have already provided interesting information 
(Mitiku and Baker, 2007).
The Neural Crest
After gastrulation in vertebrates, the epidermal and neural ter-
ritories are progressively defined along the rostrocaudal axis, 
and the neural crest forms at the boundary between these two 
territories. Neural crest cells undergo EMT within the dorsal 
neural epithelium, and individual cells migrate before giving 
rise to different derivatives, including craniofacial structures, 
most of the peripheral nervous system, some endocrine cells, 
and melanocytes.
Our understanding of how the neural crest territory is speci-
fied has increased substantially over the last 10 years, although 
the gene regulatory network operating during neural crest 
development is less complete than at gastrulation (Sauka-
Spengler and Bronner-Fraser, 2008). A complex set of induc-
tive events initiated before and during gastrulation define a 
distinct territory at the junction between neural and nonneural 
ectoderm. The neural crest territory is delimited by FGF, Wnt, 
Notch, and retinoic acid signaling pathways in cooperation with 
opposing gradients of bone morphogenetic protein 4 (BMP4) 
and its antagonists Noggin, Follistatin, and Chordin. Although 
canonical Wnt signaling is important for both the induction and 
stabilization of neural crest precursors and for their delamina-
tion, noncanonical Wnt signaling is important for neural crest 
migration (De Calisto et al., 2005; Carmona-Fontaine et al., 
2008). Thus, most of the signaling pathways involved in defin-
ing the neural crest territory are common to those used during 
gastrulation.
The presumptive neural crest is modified by the neural plate 
border specifiers Msx1, Msx2, Dlx3, Dlx5, Pax3, Pax7, and 
Zic1, which induce genes that trigger different programs in the 
neural crest such as Snail and Sox factors, FoxD3, AP2, c-Myc, 
and Id. Although organized in a hierarchy, these factors can 
also regulate expression of each other (Sauka-Spengler and 
Bronner-Fraser, 2008).
Regulation of Cell Adhesion and Movement
Cadherin-mediated adhesion also plays a major role in neu-
ral crest cell EMT, where delamination from the neural fold 
involves the downregulation of N-cadherin and Cadherin 6 as 
well as the de novo expression of type II cadherins, such as 
Cadherin 7 and 11 (Nakagawa and Takeichi, 1995; Vallin et al., 
1998). The less adhesive type II cadherins allow crest cells to 
migrate away from the neural tube (Chu et al., 2006). In the chick 
embryo, the onset of delamination involves N-cadherin protein 
cleavage by the ADAM 10 protease. The membrane bound 
fragment generated is then further digested by γ-secretase. It 
then translocates to the nucleus together with β-catenin where 
it activates cyclin D1 and promotes exit from the G1 phase, 
a prerequisite for the emigration of these cells (Shoval et al., 
2007). Interestingly, Snail factors prevent entry into the S phase 
of the cycle by repressing cyclin D transcription (Vega et al., 
2004), probably synchronizing the premigratory crest popula-
tion so that all the cells can simultaneously enter into the S 
phase upon N-cadherin cleavage and cyclin D activation. At 
least in the chick embryo, Cadherin 6B (Cad6B) is transiently 874 Cell 139, November 25, 2009 ©2009 Elsevier Inc.expressed at the premigratory phase, and its downregula-
tion leads to premature neural crest cell migration, whereas 
its overexpression induces accumulation of crest cells at the 
dorsal border of neural tube (Coles et al., 2007). The precise 
timing of Cad6B downregulation is directly controlled by Snail2 
(Taneyhill et al., 2007).
In addition to cadherins, small GTPases also play an impor-
tant role in neural crest EMT as they do during gastrulation. 
RhoV downregulation affects Sox9, Snail2, and Twist expres-
sion in Xenopus embryos (Guemar et al., 2007). Rac1 can 
induce Snail2 expression in the neural crest in Xenopus, and its 
dominant negative or activated forms markedly affect crest cell 
delamination. RhoA has the opposite effect, as its activated 
form abrogates crest cell delamination (Broders-Bondon et al., 
2007) and RhoB lies downstream of Snail2 and Sox5 in the 
chick neural crest (del Barrio and Nieto, 2002; Perez-Alcala et 
al., 2004). RADIL, a downstream effector of Rap GTPase that 
links the plasma membrane with the actin cytoskeleton, con-
trols neural crest cell adhesion and migration in zebrafish (Smo-
len et al., 2007), whereas RhoA and Rac1 control both FoxD3 
and Snail1 expression. Thus, the small Rho-GTPases play a 
major role in establishing a transcription factor autoregulatory 
network at the time of neural crest specification and EMT.
As in gastrulation, in vivo cell imaging analysis of chick neu-
ral crest has provided interesting information about the individ-
ual cell movements and the contacts that crest cells maintain 
or create while migrating (Teddy and Kulesa, 2004). Elegant 
analyses at the single-cell resolution in Xenopus embryos have 
shown that contact inhibition of locomotion mediated by Wnt 
noncanonical signaling is a crucial mechanism for the direc-
tional movements of neural crest cells toward their target tis-
sue (Carmona-Fontaine et al., 2008).
In summary, analogous signaling pathways operate dur-
ing EMT in gastrulation and neural crest formation. It is worth 
noting here that while defects in individual genes lead to very 
strong EMT phenotypes at gastrulation, there is a high degree 
of cooperation and plasticity during neural crest development. 
The existence of regulatory loops among the different EMT 
inducers in the neural tube explains why the absence of one 
player may be compensated for by the others. For instance, 
although Snail is crucial for gastrulation in all metazoans ana-
lyzed (Carver et al., 2001; Nieto et al., 1994, Wu et al., 2007), 
mice mutant for Snail1 and Snail2 still generate neural crest 
even though they develop multiple craniofacial defects (Murray 
and Gridley, 2006). This plasticity and cooperation endows the 
system with robustness, perhaps reflecting the importance of 
the neural crest as an evolutionary novelty fundamental for the 
development of the vertebrate head.
Secondary EMT: Somites, Palate, Pancreas, Liver, and 
Reproductive Tracts
The primary EMTs are followed by differentiation events that 
generate different cell types. Indeed, the migratory neural crest 
cells follow stereotyped pathways and then differentiate into 
neurons, cartilage, or bone cells, and mesodermal cells sub-
divide into axial, paraxial, intermediate, and lateral mesoderm 
after gastrulation. These populations condense into transient 
epithelial structures through a MET process, thereby forming 
the notochord, the somites, the precursors of the urogenital 
system and the somatopleure and splanchnopleure, respec-
tively (Figure 1B). Except for the notochord and in response to 
signals from their microenvironment, these secondary epithelia 
undergo a secondary EMT to generate mesenchymal cells with 
a more restricted differentiation potential.
The repression of Snail factors controls the timing of pre-
somitic axial mesoderm MET, which leads to somite epithe-
lialization (Dale et al., 2006; Morales et al., 2007). This epi-
thelialization is strictly controlled by Rac1 and Cdc42 (with 
high levels of Cdc42 promoting a mesenchymal phenotype), 
whereas Paraxis drives epithelialization by regulating the lev-
els of activated Rac1 (Nakaya et al., 2004). The somites later 
undergo various secondary EMT processes (Figure 1B). For 
example, the dorsal part of the somite converts into dermal 
mesenchyme, and myoblasts that delaminate from the myo-
tome contribute as progenitors of muscle and satellite cells 
(Gros et al., 2005). A distinctive EMT event occurs in myotomes 
at the axial limb bud level, which become populated by actively 
migrating myoblasts that detach from the tip of the myotome 
(Buckingham et al., 2003). Hepatocyte growth factor/scatter 
factor (HGF/SF) activation of the PI3K and Src pathways con-
trol this process through its receptor c-Met (Maina et al., 2001). 
In turn, the ventral part of the somites transforms into scle-
rotomal mesenchyme cells that will later form the vertebrae. 
Inducers produced by the notochord and the ventral neural 
tube control this EMT. Noggin, which antagonizes BMP signal-
ing, and sonic hedgehog (SHH) are required for the induction 
of Pax1, Pax9, and Nkx3.1, the earliest markers of sclerotomal 
cells (Monsoro-Burq, 2005). Yet it remains unclear how this 
process is controlled given that EMT still occurs in the ventral 
compartment in Pax1/9 or Nkx3.1 mutants.
The lateral plate mesoderm condenses into two epithe-
lia separated by a cavity, the coelom. Cells from the ventral 
epithelia, the splanchnopleure, undergo EMT and generate 
endocardial progenitors, angioblasts, and hematopoietic stem 
cells. Cells from the dorsal epithelia, the somatopleure, mostly 
conserve their epithelial morphology, although some cells 
undergo a further EMT to form the connective tissue of body 
wall muscle.
Endodermal derivatives also appear to use EMT during liver 
development (Tanimizu and Miyajima, 2007), although this is 
not well documented at the molecular level (Figure 1B). Pan-
creatic endocrine cells specified in the bud also delaminate 
and migrate through the surrounding mesenchyme before they 
undergo MET to form the langerhans islets (Johansson and 
Grapin-Botton, 2002).
EMT processes are also important during normal develop-
ment of secondary palate and reproductive tracts. After the 
fusion of the epithelia of the two palatal halves, it is still not 
clear whether these cells undergo EMT, die, or migrate to the 
oral epithelium. Each of these processes probably contribute, 
with some cells undergoing EMT and rapidly dispersing within 
the adjacent mesenchyme and others undergoing apopto-
sis (Martínez-Álvarez et al., 2004; Ahmed et al., 2007; Dudas 
et al., 2007). In male reproductive tracts, the Mullerian duct 
regresses after the EMT induced by the Mullerian-inhibiting 
substance (Zhan et al., 2006). Furthermore, testicular cords form upon the migration of mesonephric endothelial cells most 
likely after undergoing EMT or, more precisely, endothelial to 
mesenchyme transition (EndMT) (Combes et al., 2009).
From Primary to Tertiary EMT: Heart Development
The heart forms through three successive cycles of EMT and 
MET. Although cardiac mesodermal cells are specified during the 
EMT at gastrulation (Figures 1B and 1C), cardiac progenitors in 
the splanchnopleure quickly become organized into a two-lay-
ered epithelium via MET. A secondary EMT occurs when the two 
cardiogenic areas fold around the primitive foregut. Mesenchy-
mal cells arising from this delamination give rise to the endothelial 
cell lining of the heart through another MET, forming an endocar-
dial tube surrounded by the myocardial epithelium. Subsequently, 
these two concentric tubes develop into the four compartments 
of the heart primordium. Endothelial cells from the atrioventricular 
canal undergo a tertiary EMT (here also called EndMT due to the 
nature of the tissue of origin), invade the cardiac jelly, and form the 
endocardial cushion, the cells that later assemble into the atrio-
ventricular valvulo-septal complex (Nakajima et al., 2000).
During cardiac valve formation in the chick, TGFβ2 activates 
TGFβRIII to initiate EMT, and TGFβ3-activating TGFβRII promotes 
invasion into the cardiac cushion (Mercado-Pimentel and Runyan, 
2007). Notch regulates TGFβ2 production through translocation 
of its cytoplasmic domain to the nucleus, where it coactivates 
the Su(H)/RBPjk/CBf1 transcription factor. Target genes include 
Snail1 and the three members of the bHLH Hey family of tran-
scription factors. Snail1 represses VE-cadherin transcription and 
promotes EMT (Timmerman et al., 2004), and inactivation of Hey2 
causes major congenital heart defects and inactivation of Hey1 
and HeyL, suggesting that these two factors cooperate in EMT 
and that their combined inactivation induces ventricular septal 
and atrioventricular pulmonary valve defects (Fischer et al., 2007). 
By contrast, heterozygous mutations in the Gata4 transcription 
factor lead to severe cardiac defects in humans, as it lies upstream 
of MAPK in the ErbB3 signaling pathway required for the EMT of 
endocardial cells in the atrioventricular canal (Rivera-Feliciano et 
al., 2006). Thus, the EMT that forms the valves is controlled by 
three distinct pathways, triggered by TGFβR, Notch, and ErbB.
EMT as a Physiological Response to Injury
Processes similar to EMT also occur as a physiological 
response to injury. During wound healing, keratinocytes at 
the border of the wound recapitulate part of the EMT process. 
They appear to acquire an intermediate phenotype known 
as the “metastable” state, which allows them to move while 
maintaining loose contacts rather than migrating as individual 
cells. Snail2 expression in keratinocytes at the migratory front 
influences this state, as its inactivation or overexpression com-
promises or accelerates wound healing, respectively (Arnoux 
et al., 2008). In addition, in each menstrual cycle the ovarian 
surface epithelium undergoes an EMT-like process during pos-
tovulatory wound healing. This EMT is induced by epidermal 
growth factor (EGF) and involves the activation of metallopro-
teases and of ILK and ERK kinases (Ahmed et al., 2006).
During zebrafish cardiac regeneration, reactivation of devel-
opmental programs stimulates a rapid expansion of the entire 
epicardial cell layer, whereas the myocardium is regenerated by Cell 139, November 25, 2009 ©2009 Elsevier Inc. 875
Figure 3. EMT and Renal Fibrosis
(A) Aberrant Snail1 activation in the adult kidney is sufficient to induce renal fibrosis and renal failure in transgenic mice. The morphology of the tubules is 
disrupted and there is aberrant accumulation of Collagen fibers in the extracellular matrix. (Images from Boutet et al., 2006. Reprinted by permission from 
Macmillan Publishers Ltd.: EMBO J. 25, 5603–5613, copyright 2009.)
(B) TGFβ signaling regulates several pathways including that leading to Snail1 activation, which triggers EMT and the conversion of epithelial cells into myofi-
broblasts expressing and secreting collagen I. Inhibition of TGFβ signaling by BMP7 or the vitamin D analog paricalcitol are promising strategies to attenuate 
renal fibrosis. The pathways activated by TGFβ signaling are shown in bold.progenitor cells. A subpopulation of the tbx18-positive activated 
epicardial-derived cells must undergo an Fgf17b/Fgfr2, Fgfr4-
dependent EMT, required to invade the regenerating myocar-
dium and facilitate coronary neovascularization (Lepilina et al., 
2006). In this sense, the organism may reactivate EMT-like pro-
grams as a strategy to recover tissue homeostasis.
Pathological EMT
Organ Fibrosis
EMT not only occurs during embryonic development or as a 
physiological response to injury, but is also an important ele-
ment in cancer progression and other pathologies that involve 
organ degeneration, such as fibrosis. At the cellular level, path-
ological EMTs are very similar to physiological EMTs in that 
they are governed by similar signaling pathways, regulators, 
and effector molecules.
In fibrotic tissues, myofibroblasts accumulate and secrete 
an excessive amount of collagen that is deposited as fibers, 
thereby compromising organ function and leading to its failure. 
Fibrosis had been thought to originate through the pathologi-
cal activation of interstitial fibroblasts that convert to myofibro-
blasts to form the fibrotic collagen network. However, elegant 
cell tracing studies have shown that a significant portion of 
these myofibroblasts arise from the conversion of epithelial 
cells through an EMT process (Iwano et al., 2002). Initially dem-
onstrated in differentiated cells of renal tubules and ducts, it is 
now clear that lens epithelium, endothelium, hepatocytes, and 
cardiomyocytes can all undergo EMT and contribute signifi-
cantly to tissue fibrosis. Indeed, lineage-tracing in transgenic 
mice also indicates that hepatocytes undergo EMT during 876 Cell 139, November 25, 2009 ©2009 Elsevier Inc.CCL4-induced liver fibrosis (Zeisberg et al., 2007b), as do the 
alveolar epithelial cells during the pulmonary fibrosis induced 
by TGFβ (Kim et al., 2006). Interestingly, hepatocytes derived 
from cirrhotic livers also display characteristics of EMT, which 
has implications for the progression to hepatocellular carci-
noma (Nitta et al., 2008).
EMT involving transformation of endothelial cells into mes-
enchymal cells is evident during cardiac and renal fibrosis 
(EndMT) (Zeisberg et al., 2007a, 2008). Mesothelial cells are 
also converted to mesenchyme in patients that receive ambu-
latory peritoneal dialysis and that develop peritoneal fibrosis 
(Yanez-Mo et al., 2003), a process that involves the MAPK 
pathway and Snail1 activation (Strippoli et al., 2008). Further-
more, the EMT undergone by lens epithelial cells contributes to 
capsular opacification after cataract surgery. Prevention of this 
EMT process is achieved by transient adenoviral gene trans-
fer of the TGFβ signaling inhibitor Smad7 (Saika et al., 2004). 
TGFβ also participates in the renal fibrosis induced after uni-
lateral ureteral obstruction, and high levels of TGFβ have been 
found in fibrotic tissues from patients. Accordingly, mouse 
models lacking Smad3, a signaling molecule downstream 
of TGFβ receptors, are protected against renal fibrosis (Sato 
et al., 2003), indicating that inhibition of TGFβ signaling is a 
promising strategy to treat the disease. Accordingly, systemic 
injection of the endogenous TGFβ antagonist BMP7 can revert 
renal fibrosis in mice (Zeisberg et al., 2003), and paricalcitol, 
a synthetic vitamin D analog that suppresses the expression 
of TGFβ and of its type I receptor, also attenuates ureteral 
obstruction-induced renal fibrosis (Figure 3) (Tan et al., 2006). 
TGFβ is the main inducer of Snail1 in different contexts, and, 
interestingly, activation of Snail1 alone in the adult kidney is 
sufficient to induce renal fibrosis and renal failure (Boutet et al., 
2006). Furthermore, high levels of Snail1 have been detected in 
fibrotic kidneys from patients subjected to nephrectomy. Given 
that the high levels of TGFβ observed during fibrosis may be 
part of the physiological response to an insult or pathological 
state, and given that Snail appears to transduce the deleteri-
ous effects of TGFβ, inhibition of Snail may perhaps be a more 
specific alternative to treat kidney disease that would preserve 
the beneficial effects of TGF-β secretion.
Cancer Progression
Although EMT processes are documented in many in vitro 
cancer cell models, the significance of EMT during cancer 
progression and even its relevance in human cancer tissues 
has remained a matter of debate until very recently. This resis-
tance was mainly due to the lack of convincing evidence of 
EMT in clinical samples. Yet, EMT may be a focal event that 
is easily overlooked. Interestingly, systemic spread has been 
detected from early lesions in HER-2 transgenic mice and in 
human ductal carcinoma suggesting that metastasis is not 
necessarily a late event in tumor progression (Hüsemann et al., 
2008). More importantly, individual mesenchymal cells derived 
from epithelial tumor cells after EMT are very difficult to distin-
guish from stromal cells or other tumor-associated fibroblasts. 
The description of cords or small aggregates of tumor cells 
extending or detaching from the tumor mass into the adjacent 
stroma have recently provided morphological evidence of EMT 
at invasive fronts of human tumors (Prall, 2007). Similarly, in 
colon carcinoma, EMT occurs at the invasive front and pro-
duces single migratory cells that lose E-cadherin expression. 
This is concomitant with deregulation of the Wnt pathway 
and a selective loss of the basement membrane (Brabletz et 
al., 2001). This phenomenon is recapitulated by other solid 
tumors, as the invasive fronts in papillary thyroid carcinoma 
or in some breast carcinoma reveal an EMT expression profile, 
and those in cervical carcinoma show increased vimentin and 
loss of E-cadherin (see the Supplemental Data available online 
for additional discussion and references for different types of 
carcinoma). The invasive front of carcinoma is the immediate 
interface for tumor and stromal signals. EMT at this interface 
reflects the intricate counterbalance between internal growth 
pressure exerted by the expanding main tumor nest and the 
free edge of the tumor periphery. However, EMT-independent 
machinery such as podoplanin-mediated actin remodeling 
governs collective movements at the tumor invasive front in the 
majority of squamous cell carcinoma (Wicki et al., 2006). This 
suggests that EMT-dependent and -independent invasion can 
occur synchronously at the invasive front. Direct in vivo imag-
ing has also yielded evidence of EMT in cancer progression 
(Wyckoff et al., 2007).
Many important EMT drivers such as SNAIL1 and SNAIL2 
have been shown to correlate significantly with disease relapse 
and survival in patients with breast, colorectal, and ovarian 
carcinoma, which indicates that EMT leads to poor clinical out-
comes. Many studies have demonstrated that EMT profiles are 
associated with certain clinicopathological parameters such 
as histological grades and tumor subtypes as in basal-like and 
metaplastic breast carcinoma, usually belonging to the group with worse outcomes. In addition, suppression of EMT can 
increase the sensitivity to EGF receptor-targeted treatments 
in cell line models (hepatoma and pancreatic carcinoma), as 
well as in lung cancer patients. Thus, the identification of EMT 
features in tumor samples might provide a tool to better stratify 
patients and predict outcomes.
EMT Inducers
The loss of E-cadherin expression is considered a crucial 
step in the progression of papilloma to invasive carcinoma 
(Perl et al., 1998), and it is also a fundamental event in EMT. 
Much effort has been devoted to understanding how E-cad-
herin is regulated during cancer progression. We can now 
classify E-cadherin repressors into two groups depending 
on their effects on the E-cadherin promoter. Snail, Zeb, 
E47, and KLF8 factors bind to and repress the activity of 
the E-cadherin promoter (Peinado et al., 2007; Wang et al., 
2007b) (see Table S1 for references), whereas factors such 
as Twist, Goosecoid, E2.2, and FoxC2 repress E-cadherin 
transcription indirectly (Figure 4) (Yang and Weinberg, 2008; 
Sobrado et al., 2009).
Snail factors bind to E-box consensus sequences in the 
E-cadherin promoter with the help of local modifications of 
chromatin structure after the recruitment of SIN3A, histone 
deacetylases HDAC1 and HDAC2, and components of the Poly-
comb 2 complex (Cano et al., 2000; Batlle et al., 2000; Fraga 
et al., 2004; Herranz et al., 2008). In addition to being tightly 
regulated at the transcriptional level, Snail factors undergo 
posttranslational modifications that control their nuclear local-
ization or degradation. These modifications include phospho-
rylation by PAK and GSK3β, dephosphorylation by the small 
C-terminal domain phosphatase (SCP), and lysine oxidation by 
Figure 4. E-cadherin Transcription in Normal and Cancer Cells
SNAIL, ZEB, E47, and KLF8 factors directly repress E-cadherin transcription 
whereas Twist, Goosecoid, E2.2, and Foxc2 are indirect E-cadherin repres-
sors. Snail1 activates the expression of the ZEB genes by different mecha-
nisms, including the induction of a natural antisense transcript for ZEB2 (NAT). 
The miR-200 family and in some cases also miR-205, represses the transcrip-
tion of ZEB genes preventing EMT. A loop of miRNAs and ZEB factors cross-
regulation plus the cooperation of several EMT inducers reinforces the control 
of the EMT process. Preliminary data indicate that Snail1 may also repress 
the expression of the miR-200 family. Whether miRNAs can also control Snail 
expression awaits further investigation. EMT, epithelial to mesenchymal tran-
sition; MET, mesenchymal to epithelial transition.Cell 139, November 25, 2009 ©2009 Elsevier Inc. 877
LOXL2 (Figure 5) (Peinado et al., 2007; Wu et al., 2009b). Snail1 
protein stabilization is promoted by NFκB, which prevents its 
phosphorylation by GSK-3 and subsequent degradation (Wu 
et al., 2009a), whereas the formation of a ternary complex 
between wild-type p53, the ubiquitin ligase Mdm2, and Snail2 
triggers its degradation (Wang et al., 2009a). Cap-independent 
translation of Snail mRNA is activated by the transcription/
translation regulator Y-box binding protein 1 (YB-1), associated 
with breast cancer aggresiveness (Evdokimova et al., 2009).
Another breast cancer-associated protein that increases Snail 
nuclear translocation is the zinc transporter LIV1. LIV1 induces 
EMT during zebrafish development (Yamashita et al., 2004) and 
Figure 5. EMT Signaling Pathways
A plethora of signaling pathways and agents induce EMT in numerous cellular 
contexts, both during embryonic development and in human pathologies. The 
figure shows the target tissues and the biological process below the corre-
sponding signal that promotes EMT. Although the expression of several tran-
scription factors is an essential aspect of the EMT program, some of these 
transcription factors are also regulated at the posttranslational level through 
their subcellular localization and the regulation of their degradation by the 
proteasome. AMF, autocrine motility factor; E-cad, E-cadherin; EGF, epider-
mal growth factor; FGF, fibroblast growth factor; BMP, bone morphogenetic 
protein; IGF, insulin-like growth factor; ILEI, interleukin-related protein; ILK, 
integrin-linked kinase; IL-6, interleukin-6; LOXL, lysyl oxidase-like proteins; 
MTA3, metastasis-associated protein 3; PDGF, platelet derived growth factor; 
TGFβ, transforming growth factor β; TNF-α, tumor necrosis factor α; PAK-1, 
p21-activated kinase 2; PTH(rP)R, parathyroid hormone related peptide re-
ceptor; SCF, stem cell factor; SCP, small C-terminal domain phosphatase; 
UV, ultraviolet light; VEGF, vascular endothelial growth factor, YB-1, Y-box 
binding protein.878 Cell 139, November 25, 2009 ©2009 Elsevier Inc.promotes invasive properties in tumor cells (Unno et al., 2009). 
Being pleiotropic proteins, Snail factors may require the coop-
eration of tissue-specific binding partners to regulate transcrip-
tion. For example, Ajuba Lim proteins (Ajuba, LIMD1 and WTIP) 
act as corepressors of Snail1 and Snail2 during neural crest 
formation in Xenopus embryos (Langer et al., 2008). Snail can 
also bind to Smad proteins, which act as corepressors during 
TGFβ-induced EMT (Vincent et al., 2009). Interestingly, the levels 
of expression of the transcriptional coregulators CtBP and p300 
are critical for SNAI1 and ZEB1 function in colon carcinoma 
(Peña et al., 2006). Furthermore, the enhancement of Wnt signal-
ing promoted by Snail results both from an increase in cytoplas-
mic β-catenin due to the loss of E-cadherin and the disorganiza-
tion of junctions and from its physical interaction with β-catenin, 
which promotes Wnt signaling in a direct manner (Stemmer et 
al., 2008). Zeb genes activation occurs frequently upon Snail 
activation, as Snail1 has been found to activate Zeb1. However, 
ZEB is active in some tumors that lack SNAIL expression (Peña 
et al., 2006), and thus the regulation of Zeb expression should 
be analyzed independently because the contribution of different 
EMT inducers is dependent on the cellular context. For instance, 
ZEB1 expression is important during colon cancer progression, 
whereas ZEB2 has been studied in ovarian, gastric, and pan-
creatic tumors, where it is associated with invasiveness and 
aggressive behavior (reviewed in Peinado et al., 2007).
The Kruppel-like factor 8 (KFL8) induces EMT and tumor 
invasion in breast cell lines after directly binding to the E-cad-
herin promoter through GT boxes (Figure 4). Indeed, there is 
an inverse correlation between E-cadherin and KFL8 expres-
sion in lymph node positive breast tumors (Wang et al., 2007b). 
Twist and Goosecoid also downregulate E-cadherin expres-
sion, albeit indirectly (Yang and Weinberg, 2008). FoxC2, 
which lies downstream of Twist, Snail, and Goosecoid, does 
not affect Cadherin expression, but rather it promotes its cyto-
plasmic localization, and its main role seems to be the induc-
tion of mesenchymal properties. Twist, Goosecoid, and FoxC2 
are all associated with the metastatic potential (Figure 4) (Yang 
and Weinberg, 2008).
Regardless of the mechanism, E-cadherin repressors func-
tion as full EMT inducers in many cell contexts, regulating the 
expression of a variety of genes repressing the epithelial char-
acter and promoting the mesenchymal state. In addition, they 
repress epithelial cell polarity and cell division while promoting 
cell survival (Barrallo-Gimeno and Nieto, 2005; Peinado et al., 
2007). Attenuation of cell proliferation favors invasion versus 
tumor growth, and resistance to cell death confers a selec-
tive advantage on embryonic migratory or cancer invasive cells 
to populate distant organs. Thus, rather than being strictly 
repressors of E-cadherin expression, they are regulators of the 
epithelial phenotype and of cell adhesion and movement (see 
Table S1 for a comprehensive list of targets and references). 
The EMT inducers that indirectly repress E-cadherin transcrip-
tion frequently activate some of the direct repressors, and they 
also have multiple specific targets.
Loss of Cell Polarity in EMT
The loss of cell polarity is a crucial step for EMT. In epithelial 
cells, three protein complexes participate in establishing and 
maintaining apicobasal polarity (Par, Crumbs, and Scribble), 
and components of the three are regulated by EMT inducers 
(see review by Moreno-Bueno et al., 2008, and Table S1 for 
additional references). SNAIL1 alters epithelial cell polarity by 
repressing the transcription of Crumbs3 and abolishing the 
localization of both Par and Crumbs complexes at the junctions 
(Whiteman et al., 2008). Similarly, Zeb1 directly represses the 
transcription of cell polarity genes, including Crumbs3, Pals1-
associated tight junction proteins (PATJ), and the member of 
the Scribble complex Lethal giant larvae (Lgl2) (Spaderna et 
al., 2008). TGFβ contributes to the loss of cell polarity during 
EMT in two ways, through the canonical pathway by inducing 
Snail and Zeb genes expression and through a noncanonical 
pathway that involves the downregulation of Par3 expression 
and the Par6-mediated degradation of RhoA and local altera-
tion of the actin cytoskeleton (Ozdamar et al., 2005; Wang et 
al., 2008).
Proteases and the ECM Network
Snail and Zeb factors induce the expression of metallopro-
teases that can degrade the basement membrane, thereby 
favoring invasion (see Table S1 for references). Interestingly, 
some proteases are sufficient to induce EMT perhaps by trig-
gering a positive regulatory feedback loop that stabilizes EMT. 
MMP3 triggers EMT by increasing the cellular levels of reac-
tive oxygen species, which in turn induces Snail1 expression 
(Radisky et al., 2005). MMP13 also likely triggers EMT after 
being strongly induced by FGF1 (Billottet et al., 2008). Eplysin 
can also induce EMT through TGFβ activation (Illman et al., 
2006). The transmembrane serine protease TMPRSS4 is over-
expressed in colon carcinoma cell lines, in which it induces 
EMT after Zeb transcription and E-cadherin downregula-
tion, promoting metastasis in nude mice (Jung et al., 2008). 
Finally, Periostin, an extracellular matrix protein secreted by 
osteoblasts, interacts with integrins and signals mainly via the 
PI3-K/Akt to promote EMT, invasion, and metastasis (Ruan et 
al., 2009).
Hierarchy and Cooperation
Cooperation between different transcription factors is a hall-
mark of EMT induction. The expression of Snail1, Snail2, Twist, 
and Id2 is controlled during TGFβ-induced EMT by the high-
mobility group protein HMGA2, which behaves as an integrator 
of TGFβ signaling by using Snail1 as its downstream master 
effector (Thuault et al., 2008). Another factor that cooperates 
with TGFβ is the homeodomain-containing protein Six1, which 
works by increasing TGFβ signaling and induces EMT and 
metastasis when overexpressed in mammary gland epithelial 
cells (McCoy et al., 2009; Micalizzi et al., 2009). Conversely, the 
Mi-2/NuRD transcriptional complex behaves as a suppressor 
of breast tumor invasion and metastasis by incorporating into 
the complex the metastasis tumor antigen MTA3 or the lysine-
specific demethylase LSD1, that prevent EMT by repressing 
Snail expression or by an epigenetic mechanism that inversely 
correlates with TGFβ signaling, respectively (Fujita et al., 2003; 
Wang et al., 2009b).
Interestingly, the Snail1 and Snail2 promoters contain 
AP1 and AP4, Smad and LEF responsive elements. There is 
increasing evidence of a hierarchy that controls the expression 
of these transcriptional regulators of EMT. Both in develop-
ment and during carcinoma progression, Snail1 is expressed at the onset of the transition, whereas Snail2, Zeb genes, E47, 
and Twist are subsequently induced to maintain the migratory 
mesenchymal state (Peinado et al., 2007). As such, Snail1 and 
Snail2 cooperate in primary tumor growth and in site-directed 
metastasis formation (Olmeda et al., 2008). Snail1 induces the 
expression of Snail2 in fibrosis, and Snail1 upregulates the 
expression of Zeb proteins in carcinoma cells (Table S1). The 
control of Zeb2 expression by Snail1 is mediated by the regu-
lation of a natural antisense transcript in tumor cells (Figure 
4). The natural antisense transcript prevents the splicing of an 
intron in the 5′ untranslated region of the Zeb2 gene, increasing 
Zeb2 expression levels. This mechanism may be important in 
the maintenance of the mesenchymal state after EMT (Beltran 
et al., 2008).
New EMT Inducers
In addition to the many pathways triggered by membrane 
receptors, new intracellular molecules and external agents have 
recently been described as inducers of EMT. For instance, two 
tyrosine phosphatases, Pez and PRL3, both promote EMT. Pez 
is induced by TGFβ, and its expression is sufficient to trigger 
EMT in MDCK cells through the induction of both Snail and Zeb 
genes. Pez also induces the production of TGFβ, generating 
an autocrine activation loop (Wyatt et al., 2007). In embryos, 
Pez is expressed at sites of morphogenesis, partially associ-
ated with TGFβ3, making it likely to participate in the EMT that 
leads to the formation of cardiac valves (Wyatt et al., 2007). In 
turn, the dual specificity protein tyrosine phosphatase PRL3 
induces EMT in a colon carcinoma line by activating PI3K/
AKT. Stimulation of this pathway augments the degradation of 
PTEN and activates Snail1 (Wang et al., 2007a), possibly rein-
forcing PTEN repression given that PTEN is a direct target of 
Snail repression during radiation-induced apoptosis (Escriva 
et al., 2008). PRL3 also induces EMT through Src activation in 
a kidney cell line (Liang et al., 2007). The cytoplasmic kinase, 
Aurora-A, acting through the MAPK pathway, can induce EMT 
in nasopharyngeal tumor cells (Wan et al., 2008).
The mucin Podoplanin triggers EMT in MDCK cells by acti-
vating RhoA (Martin-Villar et al., 2006). By contrast, after inhib-
iting RhoA, podoplanin promotes collective MCF7 epithelial 
migration through the acquisition of filopodia and the loss of 
stress fibers. Podoplanin is expressed at the invasive front in 
an in vivo pancreatic tumor model, augmenting the frequency 
of high-grade tumors, although these invasive cells still retain 
E-cadherin expression (Wicki et al., 2006). Perhaps further 
analysis of the invasive front in human tumor specimens at 
the single-cell resolution will clarify the relationship between 
E-cadherin and podoplanin expression.
The L1 cell adhesion molecule, a member of the immuno-
globulin superfamily, induces EMT in epithelial breast carci-
noma cell lines by promoting adherens junction breakdown 
and the nuclear localization of β-catenin (Shtutman et al., 
2006). Similarly, an interleukin-related molecule (ILEI) can 
induce EMT and metastatic properties in various cell lines; ILEI 
is overexpressed in tumors, where it correlates with metastasis 
and poor survival (Waerner et al., 2006). Likewise, interleukin-6 
(IL-6) also promotes EMT in breast cancer cells, and Snail can 
induce IL-6 expression (Lyons et al., 2008; Sullivan et al., 2009), Cell 139, November 25, 2009 ©2009 Elsevier Inc. 879
Figure 6. EMT and Tumor Progression
(A) EMT inducers as metastasis promoting agents. In the fibrotic or tu-
moral microenvironment hypoxia and inflammation favor the activation of 
EMT inducers. In addition to promoting tumor dissemination by inducing 
cell delamination and invasion of adjacent tissues, new facets of the EMT 
have been recently described that help to understand their implication in 
the metastatic potential. Both Twist and Snail confer stem cells properties, 
favoring the self-renewal of a small population of cells that can colonize 
and differentiate into secondary carcinomas. In addition, Twist also inacti-
vates the cellular safeguard mechanism of cellular senescence triggered by 
oncogenes and Snail induces immunosuppression, immunoresistance, and 
chemoresistance.
(B) EMT is now thought to play a fundamental role in tumor progression and me-
tastasis formation. Individual cells delaminate from primary tumors and migrate 
following the extracellular matrix network. Current research is actively analyzing 
the contributions of cancer-associated fibroblasts (CAF), including bone-marrow 
derived mesenchymal stem cells. Another challenge is to understand whether ma-
lignant migratory cells are cancer stem cells acting as tumor-initiating cells in the 
primary tumor (blue cells), if they are derived from somatic epithelial tumor cells 
that have undergone EMT to acquire stem cell-like properties (red cells), or some 
combination of these two possibilities. BV/LV, blood vessels/lymphatic vessels.880 Cell 139, November 25, 2009 ©2009 Elsevier Inc.generating a regulatory loop that reinforces the relationship 
between EMT and inflammatory and immune responses (Wu et 
al., 2009a; López-Novoa and Nieto, 2009). Lastly, Thymosin β4, 
overexpressed in several cancers and involved in wound heal-
ing, can promote EMT in tumor cells through the activation of 
the integrin-linked kinase (ILK) pathway (Huang et al., 2007).
Complexity in EMT Signaling Pathways
Many signaling pathways trigger EMT in both embryonic devel-
opment and in normal and transformed cell lines. The signal-
ing pathways include those triggered by different members of 
the TGFβ superfamily, Wnts, Notch, EGF, HGF, FGF, HIF, and 
many others (Figure 5). As this has been the topic of a number 
of recent reviews (e.g., Thiery and Sleeman, 2006; Yang and 
Weinberg, 2008), here, we focus on the recent additions to this 
growing list.
The vast majority of the signaling pathways known to trigger 
EMT converge at the induction of the E-cadherin repressors, 
and in particular, of the Snail genes (Figures 4 and 5). A Ras-
MAPK pathway activated by stimulation of different receptor 
tyrosine kinases can induce Snail1 and Snail2. Although HGF/
SF usually activates MAPK-independent pathways, it can acti-
vate this pathway with the cooperation of the early growth 
response factor-1 (Egr-1), which binds directly to the SNAIL1 
promoter, leading to its rapid induction and the execution of 
the EMT program (Grotegut et al., 2006). Snail1 can modulate 
the EMT response as it represses its own transcription (Peiro et 
al., 2006), while, conversely, Snail2 seems to be self-activated 
in avian neural crest (Sakai et al., 2006).
The NFκB pathway is also emerging as an important regu-
lator of EMT in carcinoma cell lines and mesothelial fibrosis, 
acting through the induction of Snail1 transcription (Julien et 
al., 2007; Strippoli et al., 2008) and protein stabilization (Wu et 
al., 2009a). The importance of this pathway is evidenced by the 
blocking of EMT elicited by nondestructible IkB, a NFκB inhibi-
tor (Huber et al., 2004).
TGFβ-induced Smad3 binds to myocardin-related tran-
scription factors (MRTFs), and it is translocated to the 
nucleus in a Rho-dependent manner to activate Snail2 in 
MDCK cells. MRTFs also activate the transcription of actin 
filament remodeling proteins, fulfilling important aspects of 
EMT, including cell scattering and reorganization of cortical 
actin cytoskeleton into stress fibers (Morita et al., 2007), and 
they are important for the metastatic ability of tumor cells 
(Medjkane et al., 2009). These pathways are also at work in 
the conversion of kidney cells to myofibroblasts, with clear 
implications for renal fibrosis (Fan et al., 2007). In the renal 
system, the von Hippel-Lindau (VHL) tumor suppressor also 
negatively regulates the hypoxia-inducible factor-1 (HIF-1), 
and VHL loss is associated with renal clear cell carcinoma 
(RCC) and E-cadherin loss. Hypoxia induces Snail and EMT 
in many cellular and tumoral contexts (reviewed in López-
Novoa and Nieto, 2009), although the cellular response may 
be associated with the concomitant induction of E47, Zeb fac-
tors, and, in particular, Twist, a direct target of HIF1-α that 
correlates with invasion and metastasis (Figure 6A) (Yang et 
al., 2008). TGFβ-induced EMT might be accelerated by addi-
tional mechanisms as occurs during gastrulation. E-cadherin 
is endocytosed via clathrin-coated vesicle in EpH4 mammary 
cells expressing inducible Raf, followed by subsequent Snail1 
activation (Janda et al., 2006).
Platelet-derived growth factor (PDGF) stimulates EMT in 
colon carcinoma cells through the nuclear translocation of 
β-catenin in a Wnt-independent manner (Yang et al., 2006c). 
A similar process may also be at work during EGF and TGFβ-
induced EMT (Gotzmann et al., 2006). EGF is known to induce 
EMT by promoting E-cadherin endocytosis (Lu et al., 2003), 
but it can also induce the expression of both Snail and Twist, 
repressing E-cadherin transcription among other targets (Lee 
et al., 2008; Lo et al., 2007).
Vascular endothelial growth factor (VEGF) signaling pro-
motes EMT in pancreatic and breast tumor cells by inducing 
Snail and Twist expression (Wanami et al., 2008; Yang et al., 
2006a). Interestingly, Snail1 can induce VEGF expression in 
epithelial cells (Peinado et al., 2004), and they are coexpressed 
during peritoneal fibrosis (Zhang et al., 2008). Hence, a regula-
tory loop between angiogenesis and EMT may contribute to 
tumor progression.
Notch induces Snail1 during heart development (Timmer-
man et al., 2004) and is also required for neural crest induction 
and differentiation (Cornell and Eisen, 2005). Recent studies 
propose Snail2 as a target of Notch signaling (High et al., 2007; 
Leong et al., 2007; Niessen et al., 2008). Interestingly, Notch 
directly promotes Snail1 activation during hypoxia through the 
binding of its processed intracellular form to the Snail promoter 
and the activation of Lox2 expression by the hypoxia factor 1 
(HIF-1), thereby stabilizing the Snail1 protein (Sahlgren et al., 
2008).
The insulin growth factor receptor (IGFR) pathway induces 
EMT through the NFκB-Snail axis in mammary epithelial cells 
and by upregulating Zeb in prostate carcinoma cells (Graham 
et al., 2008; Kim et al., 2007). Similarly, a Sonic hedgehog-Gli-
Snail1 pathway promotes EMT at the invasive front of neuroen-
docrine tumors (Fendrich et al., 2007), and it impairs the preg-
nancy-induced maturation of the mammary gland (Fiaschi et 
al., 2007). Prostaglandin E(2) acts in an autocrine or paracrine 
manner to induce both Snail and Zeb expression and EMT 
through the cyclooxygenase pathway (Dohadwala et al., 2006). 
In turn, Snail induces prostaglandin E(2) expression by repress-
ing the prostaglandin dehydrogenase, generating a loop that 
may promote cancer progression (Mann et al., 2006).
New Players: Feedback Loops by MicroRNAs and 
Alternative Splicing
Recent studies have highlighted the importance of micro-
RNA in the regulation of the epithelial phenotype by control-
ling EMT inducers (Figure 4) (reviewed in Cano and Nieto, 
2008). MicroRNAs are noncoding single strands of ?22 
nucleotides that exert a posttranscriptional control on gene 
expression by pairing their seed sequences (2–8 nucleotides 
at the 5′ end) to complementary sequences typically in the 3′ 
untranslated region of target mRNAs. This pairing results in 
the degradation of the target mRNA and/or the inhibition of 
its translation. MicroRNAs of the miR-200 family (as well as 
miR-205) have been shown to control EMT by downregulat-
ing the expression of the Zeb factors (Christoffersen et al., 
2007; Gregory et al., 2008; Hurteau et al., 2007; Korpal et al., 2008; Park et al., 2008) and to control the metastatic ability 
of cancer cells. Indeed, forced expression of miR-200 family 
components inhibits the ability of lung adenocarcinoma cell 
lines to undergo EMT, invade, and metastasize (Gibbons et 
al., 2009).
In addition to the members of the miR200 family, miR-10b, 
miR-373, and miR-520c have also been implicated in the pro-
gression of breast carcinoma (Huang et al., 2008; Ma et al., 
2007), and miR-21 is upregulated during TGFβ-induced EMT 
in tumor cell lines (Zavadil et al., 2007). Thus, a regulatory cas-
cade involving microRNAs and EMT transcriptional regulators 
is likely to contribute significantly to the progression of car-
cinoma. This hypothesis has recently been validated as Zeb1 
(and probably Snail1) can bind to the promoters of miR-141 
and -200c and suppress their expression, thereby generating a 
regulatory loop that can reinforce the ability of Zeb1 to maintain 
a stable mesenchymal phenotype, as observed at the invasive 
front of colon carcinoma cells (Burk et al., 2008) (Figure 4). As 
it occurs in the regulation of EMT inducers by extracellular sig-
nals, microRNA are starting to emerge as regulators of gene 
transcription not only in cancer cells but also during develop-
ment, perhaps reflecting an ancient role for these molecules. 
Indeed, they have been implicated in neuronal, muscle, and 
germline development (Stefani and Slack, 2008).
Alternative splicing can generate isoforms of the same gene 
with antagonistic functions, and recent studies confirm that this 
occurs during EMT. The invasion isoform of Mena (MenaINV) 
is specifically expressed in highly invasive tumor cells, and it 
facilitates cell invasion by stabilizing invadopodia (Philippar et 
al. 2008). Two RNA binding proteins, called ESRP1 and ESRP2 
(epithelial splicing regulatory proteins 1 and 2), have recently 
been shown to control the splicing of epithelial-specific forms 
of EMT-associated genes including FGFR2, Mena, CD44, 
p120-catenin, and EPB41L5 (Warzecha et al., 2009a, 2009b). 
Whether the regulation of ESRPs expression is sufficient to 
regulate EMT or MET remains to be investigated.
EMT in Cancer: More Than Invasion
Although it is clear that EMT is involved in metastatic events 
in cancer, its participation in other events may be also highly 
relevant to tumor progression.
Resistance to Cell Death and Senescence
TGFβ can prevent the progression of incipient tumors and 
promote tumor invasion and evasion of immune surveillance 
at advanced stages (Massagué, 2008), directing apoptosis or 
survival plus EMT in many cell contexts. Interestingly, EMT is 
favored and apoptosis is inhibited when TGFβ acts on activated 
Ras-expressing mammary epithelial cells, and resistance to 
TGFβ-induced cell death is associated with hepatocytes 
undergoing EMT (Valdes et al., 2002). Similarly, exposure of 
breast tumor-derived NMuMG cells to TGFβ for several weeks 
generates cells that escape apoptosis and exhibit a sustained 
EMT (Gal et al., 2008). This model offers the opportunity to 
investigate the long-term effect of chronic TGFβ exposure dur-
ing fibrosis in epithelial tissues and in cancer cells. Many cell 
lines undergo EMT in response to TGFβ over a period of days 
through a process that requires the activation of E-cadherin 
repressors. Indeed, TGFβ is a potent inducer of Snail expres-Cell 139, November 25, 2009 ©2009 Elsevier Inc. 881
sion, known to confer resistance to the cell death (reviewed 
in Barrallo-Gimeno and Nieto, 2005). This prosurvival activity 
can be extended to Twist, as it antagonizes the Myc-mediated 
proapoptotic effect in neuroblastoma (Puisieux et al., 2006).
The EMT process can also confer resistance to oncogene-
induced premature senescence. Twist1 and Twist2 prevent 
cells from undergoing senescence induced by oncogenes by 
inhibiting p16/ink4a and p21/cip (Ansieau et al., 2008). Con-
comitantly, Twist proteins cooperate with activated Ras to 
trigger full EMT and promote invasion. Interestingly, Zeb1 also 
protects mouse embryonic fibroblasts from senescence (Liu et 
al., 2008). This suggests that abrogation of senescence may be 
a general mechanism associated with EMT (Figure 6A). Thus, 
constitutive expression of EMT inducers can maintain the mes-
enchymal and invasive phenotype while ensuring the survival 
of micrometastatic cells by suppressing two safeguard mecha-
nisms against cancer: premature senescence and apoptosis.
Resistance to Chemotherapy and Immunotherapy
Tumors undergoing EMT may resist conventional chemo-
therapy, and, accordingly, colon carcinoma epithelial cell lines 
made resistant to oxaliplatin exhibit a mesenchymal morphol-
ogy and express several markers of EMT (Yang et al., 2006b). 
The resistance of ovarian carcinoma epithelial cell lines to 
paclitaxel is also associated with the acquisition of EMT mark-
ers and loss of the epithelial phenotype (Kajiyama et al., 2007). 
Twist and one of its target genes are elevated in a subset of 
MCF7 or MDA-MB-434 cells selected for their invasive proper-
ties, and, having undergone EMT, they were also resistant to 
paclitaxel (Cheng et al., 2007). Moreover, the depletion of Twist 
can partially reverse multidrug resistance in breast cancer cells 
(Li et al., 2009). Similarly, Snail also confers resistance to pacli-
taxel, adriamycin, and radiation by antagonizing p53-mediated 
apoptosis (Kajita et al., 2004; Kurrey et al., 2009) (Figure 6A). 
Snail-expressing cells and the EMT process are also associ-
ated with resistance to dendritic cell immunotherapy (Kudo-
Saito et al., 2009). Interestingly, forced expression of miR-
200c, a negative regulator of EMT, restores chemotherapeutic 
sensitivity (Cochrane et al., 2009).
Immune Surveillance, Immunosuppression, and 
 Inflammation
Tumors can escape immune surveillance by inducing toler-
ance or by modifying their phenotype through immunoedit-
ing. Indeed, Neu-driven tumors escape immune surveillance 
upon undergoing EMT (Knutson et al., 2006). Tumor relapse 
is observed in a Neu/ErBb2-inducible transgenic tumor model 
after removal of the inducer, indicating that tumors depend 
on continuous oncogenic signaling. However, all animals had 
residual foci that finally developed more aggressive new tumors 
of the EMT type (Moody et al., 2002). These two studies sug-
gest that EMT may be involved in the acquisition of resistance 
to targeted therapies and that cells belonging to the foci of 
minimal residual disease acquired a mesenchymal phenotype. 
Snail1 expression is correlated with breast tumor recurrence 
(Moody et al., 2005), and Snail is associated with the activation 
of immunosuppressive cytokines, regulatory T cells, cytotoxic 
T lymphocytes resistance, and the generation of impaired den-
dritic cells (Kudo-Saito et al., 2009). Thus, Snail and very likely 
the EMT process in general, can accelerate cancer metastasis 882 Cell 139, November 25, 2009 ©2009 Elsevier Inc.not only by increasing invasion, but also by acting on multiple 
immunosuppression and immunoresistance mechanisms, 
reflecting an alteration in the response of the host to the tumor. 
Thus, therapies directed to interfere with EMT might not only 
be anti-invasive but also able to restore immunocompetence 
in patients.
Inflammation is associated with the progression of cancer 
and fibrosis. Interestingly, recent studies point to the inflamma-
tion-induced EMT as critical to this connection (López-Novoa 
and Nieto, 2009). In the tumor microenvironment and in the 
course of organ fibrosis (such as occurs with kidney obstruc-
tion, diabetes, and glomerulonephritis) different mechanisms 
converge on the induction of NFκB, which increase the expres-
sion of EMT inducers and Snail in particular both at the tran-
scriptional and translational levels (Figure 6A) (Julien et al., 
2007; Strippoli et al., 2008; Wu et al., 2009a).
EMT Confers Stem Cell Properties
Recent evidence suggests that cells that undergo EMT acquire 
stem cell-like properties (Figure 6A) (Mani et al., 2008; Morel et 
al., 2008). Although further analyses are necessary to deter-
mine whether EMT in normal tissues leads to the production of 
normal stem cells, this intriguing concept is supported by stud-
ies on embryonic stem (ES) cells and mesenchymal stem cells. 
EMT is observed at the periphery of human ES cell clusters 
grown on matrigels (Eastham et al., 2007; Ullmann et al., 2007). 
These undifferentiated mesenchymal cells are characterized 
by a shift from E- to N-cadherin expression, the expression of 
Snail factors, vimentin, and metalloproteases. These cells also 
retain the expression of several totipotent transcription factors, 
including Oct-4 and Nanog, indicating that ES cells can adopt 
a mesenchymal phenotype without loosing their pluripotency.
Adult cells reprogrammed to pluripotency (induced pluri-
potent stem [iPS] cells) and mesenchymal stem cells share 
not only phenotypic features but also differentiation proper-
ties. Skin fibroblasts can give rise to hepatocyte-like cells, and 
these cells acquire an undifferentiated mesenchymal pheno-
type upon removal of growth/differentiation factors, remaining 
in an EMT state coexpressing mesodermal and endodermal 
markers (Lysy et al., 2007). Thus, mesenchymal status seems 
to be a condition to regain pluripotency.
Normal stem cells and cancer stem cells may share a mesen-
chymal phenotype that enhances their ability to preserve stem-
ness, to retain migratory properties, and to respond to differ-
ent stimuli during expansion and differentiation. Untransformed 
immortalized human mammary epithelial cells undergo EMT 
upon expression of Snail1 or Twist, or in the presence of TGFβ1. 
These cells adopt a mesenchymal phenotype, and, in addition 
to Twist and Snail, they also express FoxC2, Zeb factors, and 
N-cadherin. Upon transformation by activated Ras or Her2/
neu, the subpopulation of CD44high/CD24low immortalized 
human mammary epithelial cells that possess stem-like proper-
ties increases with concommittant induction of EMT phenotype 
(Morel et al., 2008; Mani et al., 2008). Interestingly, Zeb1 is also 
able to confer stem cell-like properties, reinforcing the relation-
ship between EMT and stemness (Wellner et al., 2009).
An issue that has emerged through the attempts to charac-
terize a signature for the progression of primary tumors is the 
identity of tumor-initiating cells with inherent properties to sus-
tain the growth of the tumor. An important question that arises 
is whether such initiating cells are cancer stem cells. Direct 
support for the existence of cancer stem cells in carcinoma 
has come from mouse models of epithelial tumorigenesis and 
from initial data from patients (Visvader and Lindeman, 2008). 
However, some studies suggest that tumors are not neces-
sarily initiated by rare cancer stem cells and that a significant 
percentage of individual human melanoma cells can efficiently 
form tumors (Kelly et al., 2007; Quintana et al., 2008). With the 
emergence of data indicating that EMT endows cells with stem 
cell-like properties, it will be important to determine whether 
the invasive cells disseminating from the primary tumor origi-
nate from resident stem cells or if they derive from somatic 
tumor cells that have undergone EMT. Regardless of their ori-
gin, such cells must undergo a full mesenchymal transition 
to become motile and invasive. Indeed, intravital two-photon 
microscopy demonstrates that these invasive cells delami-
nate from the primary tumor as individual cells and that they 
migrate in association with the extracellular matrix (Condeelis 
and Segall, 2003) (Figure 6B). In this process, cancer associ-
ated fibroblasts play an important role in tumor progression. 
A subpopulation of cancer-associated fibroblasts, the bone 
marrow-derived activated mesenchymal stem cells that are 
present in tumor stroma, instruct cancer cells in the primary 
tumor, enhancing their metastatic ability by promoting migra-
tion and extravasation (Figure 6B) (Karnoub et al., 2007). Inter-
estingly, these mesenchymal stem cells in the stroma do not 
induce EMT, indicating that this process occurs independently 
in carcinoma cells. In pancreatic carcinoma, there is evidence 
of the existence of two different stem cell-like populations: one 
that maintains the growth of the primary tumor and another 
that produces metastatic growth (Hermann et al., 2007). It will 
be interesting to determine whether the latter have undergone 
EMT and whether these cells originate from resident cancer 
stem cells or other carcinoma cells (Figure 6B).
Together, these data indicate that EMT may not only be nec-
essary for primary carcinoma to invade and disseminate, but 
also that these pioneer invasive cells with both a mesenchymal 
and a stem cell-like phenotype can generate a differentiated 
epithelial-like structure. This reversion to the differentiated phe-
notype through a process of MET is important for the formation 
of macrometastasis and thus to form the bulk of the secondary 
tumor mass. This hypothesis was previously formulated from 
an analysis of the progression of colon primary tumors and 
liver metastases, where it was proposed that cancer stem cells 
could acquire a mesenchymal phenotype, and thereby become 
migratory cancer stem cells that will form metastasis (Brabletz 
et al., 2005). Parallels can be found between these cells and 
the migratory embryonic cells with a mesenchymal phenotype 
that generate multiple differentiated cell types once they reach 
their destination.
Cancer Therapeutics that Target EMT Pathways
Regulating the activity of E-cadherin repressors may seem an 
obvious strategy to fight cancer progression. However, these 
inducers of the full EMT program are transcription factors, and 
are thus very difficult to target. RNA interference provides some 
hope in terms of specificity, but further development is needed to increase the stability of these reagents and the efficiency 
in cell targeting and intracellular delivery. An alternative would 
be the use of therapies based on negative regulators of EMT, 
but there is still little information or they are again transcrip-
tion factors such as the recently described KLF17 transcrip-
tion factor (Gumireddy et al., 2009). In addition, it is not known 
whether KLF17 is sufficient to revert the EMT by inducing a 
MET process. A strategy that is currently under way is to target 
the membrane receptors that transmit the extracellular signals 
that activate the EMT program.
Small-molecule inhibitors or antibodies directed against the 
EGFR, IGFR, PDGFR, cMET, TGFβR, and Endothelin type A 
receptor (ETAR) have been effective in preclinical and clinical 
trials. Although originally developed as inhibitors of cell prolif-
eration or angiogenesis, it is likely that these molecules inter-
fere with EMT (Chua et al., 2008). For instance, Cetuximab or 
panitumumab, two antibodies against EGFR, or erlotinib and 
gefitinib, two small molecules that act as competitive inhibi-
tors of the EGFR kinase, are currently used clinically to treat 
advanced carcinoma. However, studies in cell lines show that 
not all cells expressing high levels of EGFR respond to erlotinib 
or gefitinib. Interestingly, there is a clear correlation between 
the EMT status of each cell line and the degree of response 
(Frederick et al., 2007; Thomson et al., 2005; Yauch et al., 2005). 
Restoration of E-cadherin can alleviate the resistance to kinase 
inhibitors (Witta et al., 2006), and a significant response was 
observed in a Phase 3 clinical trial for E-cadherin positive non-
small-cell lung carcinoma (Herbst et al., 2005). Conversely, 
head and neck squamous cell carcinoma, pancreatic, colorec-
tal, and bladder carcinoma that express EMT markers are more 
resistant to EGFR antagonists (Buck et al., 2007; Frederick et 
al., 2007; Shrader et al., 2007).
Other signaling pathways are also being targeted to interfere 
with EMT, including the use of neutralizing antibodies against 
TGFβ, which are in Phase 1 clinical trials for renal cell carci-
noma and pulmonary fibrosis (Chua et al., 2008). Similarly, the 
inhibition of the Sonic hedgehog-Gli-Snail pathway with cyclo-
pamine has been tested in xenograft mouse models of pancre-
atic carcinoma (Feldmann et al., 2007) and in gastrointestinal 
neuroendocrine tumors (Shida et al., 2006). The lysyl-oxidase 
propeptide reverses the Her-2/neu-induced EMT and the inva-
sive phenotype, thereby providing a new target for Her-2/neu-
driven breast cancers (Min et al., 2007). The strategies to target 
the IGF/IGFR pathway were recently reviewed, including the 
use of receptor-specific antibodies, kinase inhibitors, or acti-
vators of the AMP-activated protein kinase such as metformin 
(Pollak, 2008).
At initial stages of carcinoma development, there are auto-
crine mechanisms driven by EGFR and its cognate ligands. 
However, cells that have established a stable mesenchymal 
phenotype may utilize other receptor tyrosine kinases, or 
TGFβR autocrine or paracrine loops, and they may become 
refractory to EGFR inhibitors. There is evidence for a sustained 
activation of the PI3K-AKT pathway by IGFR, suggesting that 
combined targeted therapies may be useful during the initial 
phase of treatment. In addition, PDGFR activation may also 
be required for the sustained survival, growth, and invasion of 
mesenchymal-like carcinoma (Barr et al., 2008). Inhibition of Cell 139, November 25, 2009 ©2009 Elsevier Inc. 883
the Src pathway by dasatinib is effective in mesenchymal and 
basal subtype breast carcinoma cell lines, probably because 
of the involvement of Src in signaling pathways controlling cell 
proliferation, differentiation, adhesion, motility, and survival 
(Finn et al., 2007). Thus, it would be interesting to examine 
whether dasatinib could overcome the refractiveness to EGFR 
inhibition by gefitinib and erlotinib.
Another approach to overcome refractoriness is to target 
directly the cancer stem cells. Recently, salinomycin was iden-
tified from a library consisting of 16,000 small molecules for its 
selective cytotoxity toward enriched breast cancer stem cells. 
This pioneer study provides a proof of principle that cancer 
stem cells exhibiting EMT features can be selectively targeted 
by drugs (Gupta et al., 2009).
Concluding Remarks
EMT is central to both physiological and pathological pro-
cesses (Figure 7), and pathological EMT can be regarded as 
a reactivation of developmental programs in the adult. Given 
that EMT is controlled by a network of transcriptional regu-
lators coupled to posttranscriptional and posttranslational 
modifications that amplify the initial signals, defining the gene 
regulatory networks operative during embryonic EMT will be 
fundamental to understanding those that govern EMT in can-
cer. The gene regulatory network may help assign molecular 
signatures to human tumors and pave the way for the design 
of improved specific therapies. Powerful imaging techniques 
together with lineage tracers developed to follow cell move-
ments in vivo will be essential to study migratory cancer cells 
in animal models. In particular, these approaches will make it 
possible to determine whether these migratory cancer cells 
were stem cells in origin or somatic tumor cells that acquired 
stemness upon undergoing EMT. EMT also provides an expla-
nation for the known associations between inflammation and 
Figure 7. EMT at the Crossroads of Multiple Cellular Processes884 Cell 139, November 25, 2009 ©2009 Elsevier Inc.fibrotic processes or cancer progression, and between cancer 
progression and immunosuppression. Finally, the notion that 
a mesenchymal state is required to maintain stemness opens 
new avenues to understand epithelial plasticity in health and 
disease. In addition, this standpoint may establish the foun-
dations to develop targeted therapies aimed at reverting the 
mesenchymal state into an epithelial state and at restoring 
immunocompetence.
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